Total Funding | $1.7 b |
Latest funding size | $500 m |
Time since last funding | 3 months ago |
Investors | BB Biotech Ventures, Invus, Abu Dhabi Investment Authority, Sequoia Capital China, AstraZeneca, Fidelity Management and Research Company, Julius Baer Group, RA Capital Management, Biomedical Advanced Research and Development Authority (BARDA), Alexandria Venture Investments, Viking Global Investors, Alexion Pharmaceuticals, Flagship Ventures, Wellington Management, EDBI, Pictet Private Equity Investors S.A., ArrowMark Partners, DARPA, Bill & Melinda Gates Foundation |
USD | |
---|---|
Revenue (Jun, 2016) | 36 m |
Market valuation | 7.5 b |
USD | Jun, 2016 |
---|---|
Revenue | 36 m |
USD | Y, 2016 |
---|---|
Revenue/Employee | 99.4 k |
Y, 2015 | May, 2017 | |
---|---|---|
Drugs in Development | 92 | |
Patent Applications | 250 |